Team Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Team Financial Group's ARKG Position: Q1 2024 in Review
Team Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 3 shares — an estimated $99 sold.
Team Financial Group first reported a position in ARKG in Q3 2023 and held it in 2 quarters. The position peaked at $99 in Q4 2023. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.
- Team Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
- Team Financial Group sold 3 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $99.
- Team Financial Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 2 quarters.
- Team Financial Group's ARK Genomic Revolution ETF position peaked at $99 in Q4 2023.
- 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.
Based on Team Financial Group's 13F filing for Q1 2024, filed 13 May 2024.